Serum levels of IL-6, TNF-α, and YKL-40 in patients with stage I multiple myeloma
Background & Aims: Multiple myeloma (MM) is a type of plasma cell malformation accounting for 10% of the blood cancers with unknown ethiopathology. MM causes changes in inflammatory proteins. The aim of this study was to evaluate the serum levels of IL-6, TNF-α, and YKL-40 in patients with stage...
Main Authors: | Zeinab Esmaeilzadeh, Fatemeh Kheradmand, Yousef Rasmi, Mohammad Hassan Khadem-Ansari |
---|---|
Format: | Article |
Language: | English |
Published: |
Urmia University of Medical Sciences
2020-06-01
|
Series: | Journal of Research in Applied and Basic Medical Sciences |
Subjects: | |
Online Access: | http://ijrabms.umsu.ac.ir/article-1-105-en.pdf |
Similar Items
-
Bortezomib modulates CHIT1 and YKL40 in monocyte-derived osteoclast and in myeloma cells
by: Tibullo eDaniele, et al.
Published: (2015-10-01) -
Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40
by: Camilla Bjørnbak Holst, et al.
Published: (2020-04-01) -
A Comparative Study Of Lamps And Ykl-40 Tissue Expression In Glial Tumors
by: Kazakova Maria Hr., et al.
Published: (2014-09-01) -
YKL-40 IN SERA OF BREAST TUMOR PATIENTS
by: Maria Kazakova, et al.
Published: (2010-07-01) -
Pretreatment Plasma IL-6 and YKL-40 and Overall Survival after Surgery for Metastatic Bone Disease of the Extremities
by: Michala Skovlund Sørensen, et al.
Published: (2021-06-01)